| Literature DB >> 32349198 |
Jason Pik Eu Chang1,2, Yu Jun Wong3, Wei Lyn Yang4, Kieron Boon Leng Lim5,6, Poh Seng Tan7, Gim Hin Ho1,8, Benjamin Cherng Hann Yip1,8, James Weiquan Li1,3, Chern Hao Chong1,9, David Eng Hui Ong1,6, Tju Siang Chua1,10, Charles Kien Fong Vu1,4, Kok Ann Gwee1,11, Tiing Leong Ang1,3, Chee Kiat Tan2.
Abstract
In this paper, we aim to provide professional guidance to clinicians who are managing patients with chronic liver disease during the current coronavirus disease 2019 (COVID-19) pandemic in Singapore. We reviewed and summarised the available relevant published data on liver disease in COVID-19 and the advisory statements that were issued by major professional bodies, such as the American Association for the Study of Liver Diseases and European Association for the Study of the Liver, contextualising the recommendations to our local situation. Copyright: © Singapore Medical Association.Entities:
Keywords: COVID-19; SARS-CoV-2; hepatology
Mesh：
Year: 2020 PMID： 32349198 PMCID： PMC7930298 DOI： 10.11622/smedj.2020069
Source DB: PubMed Journal: Singapore Med J ISSN： 0037-5675 Impact factor: 1.858